Mark Bunting

Mark Bunting

School of Biomedicine

Faculty of Health and Medical Sciences


Dr. Mark Bunting is a post-doctoral researcher in the Genome Editing Laboratory at the University of Adelaide and South Australian Health and Medical Research Institute (SAHRMI). The lab is directed by Prof. Paul Thomas.

Dr. Mark Bunting completed his Ph.D. in Immunology at the University of Adelaide in 2012. He then joined the lab of Prof. Geoff Hill at the QIMR Berghofer Medical Research Institute in Brisbane, Australia studying the role of mucosal associated invariant T cells (MAIT) and natural killer cells in graft-versus-host disease and leukemia preclinical models. He then undertook a second post-doctoral position in the lab of Assistant Prof. Shawn Demehri at the Massachusetts General Hospital & Harvard Medical School in Boston, USA. Here he researched the role of natural killer cells in solid organ transplantation and skin cancer preclinical models. In 2019 he moved back to Adelaide and joined the Genome Editing Laboratory.

Dr. Bunting's current research is centred around using CRISPR/Cas9 genome editing technology to develop genetic biocontrol technology in mammals as a safe and ethical method of invasive pest species control.

Dr. Mark Bunting is a post-doctoral researcher in the Genome Editing Laboratory at the University of Adelaide and South Australian Health and Medical Research Institute (SAHRMI). The lab is directed by Prof. Paul Thomas.

Dr. Mark Bunting completed his Ph.D. in Immunology at the University of Adelaide in 2012. He then joined the lab of Prof. Geoff Hill at the QIMR Berghofer Medical Research Institute in Brisbane, Australia studying the role of mucosal associated invariant T cells (MAIT) and natural killer cells in graft-versus-host disease and leukemia preclinical models. He then undertook a second post-doctoral position in the lab of Assistant Prof. Shawn Demehri at the Massachusetts General Hospital & Harvard Medical School in Boston, USA. Here he researched the role of natural killer cells in solid organ transplantation and skin cancer preclinical models. In 2019 he moved back to Adelaide and joined the Genome Editing Laboratory.

Dr. Bunting's current research is centred around using CRISPR/Cas9 genome editing technology to develop genetic biocontrol technology in mammals as a safe and ethical method of invasive pest species control.


Connect With Me
External Profiles